Ef Therapeutics Corp.
Publicly observedTampa, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Tampa | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Ef Therapeutics Corp. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | X42PJJN1JGE3 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant4 Sept 2025Publicly observed
NIH SBIR/STTR award: IntellipulseTM Platform Technology for Effective Delivery of Therapeutic Agents
USD 1,060,745.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant4 Sept 2025Publicly observed
NIH SBIR/STTR award: IntellipulseTM Platform Technology for Effective Delivery of Therapeutic Agents
USD 984,830.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.